These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
447 related articles for article (PubMed ID: 7731942)
1. DNA image cytometry and the expression of proliferative markers (proliferating cell nuclear antigen and Ki67) in non-Hodgkin's lymphomas. Czader M; Porwit A; Tani E; Ost A; Mazur J; Auer G Mod Pathol; 1995 Jan; 8(1):51-8. PubMed ID: 7731942 [TBL] [Abstract][Full Text] [Related]
2. Flow cytometric S-phase fraction as a complementary biological parameter for the cytological grading of non-Hodgkin's lymphoma. Pinto AE; Cabeçadas J; Nóbrega SD; Mendonça E Diagn Cytopathol; 2003 Oct; 29(4):194-9. PubMed ID: 14506670 [TBL] [Abstract][Full Text] [Related]
4. Proliferating cell nuclear antigen (PCNA) expression in childhood lymphomas. Kalmanti M; Kanavaros P; Sakalidou A; Tzardi M; Datseris G; Bolonaki E; Kalmantis T; Kazlaris E; Delides G Acta Morphol Hung; 1992; 40(1-4):215-21. PubMed ID: 1365765 [TBL] [Abstract][Full Text] [Related]
5. Prognostic impact of DNA ploidy pattern, S-phase fraction (SPF), and proliferating cell nuclear antigen (PCNA) in patients with primary gastric lymphoma. Belessi CJ; Parasi AS; Manioudaki HS; Laoutaris NP; Legakis NC; Peros GT; Androulakis GA J Surg Oncol; 2003 Apr; 82(4):247-55. PubMed ID: 12672009 [TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of proliferative and apoptotic fractions in low grade follicle center cell-derived non-Hodgkin's lymphomas. Czader M; Mazur J; Pettersson M; Liliemark J; Strömberg M; Christensson B; Tribukait B; Auer G; Ost A; Porwit A Cancer; 1996 Mar; 77(6):1180-8. PubMed ID: 8635141 [TBL] [Abstract][Full Text] [Related]
7. Proliferating cell nuclear antigen (PCNA), immunostaining and flow cytometric DNA analysis of renal cell carcinoma. Tanioka F; Hiroi M; Yamane T; Hara H Zentralbl Pathol; 1993 Aug; 139(3):185-93. PubMed ID: 8105885 [TBL] [Abstract][Full Text] [Related]
8. MIB-1, Ki67, and PCNA scores and DNA flow cytometry in intermediate grade malignant lymphomas. Pich A; Ponti R; Valente G; Chiusa L; Geuna M; Novero D; Palestro G J Clin Pathol; 1994 Jan; 47(1):18-22. PubMed ID: 7907607 [TBL] [Abstract][Full Text] [Related]
9. DNA synthesis and ploidy in non-Hodgkin's lymphomas demonstrate intrapatient variation depending on circadian stage of cell sampling. Smaaland R; Lote K; Sothern RB; Laerum OD Cancer Res; 1993 Jul; 53(13):3129-38. PubMed ID: 8319221 [TBL] [Abstract][Full Text] [Related]
10. Analysis of ploidy and proliferative activity in childhood non-Hodgkin's lymphoma (NHL) and Hodgkin's disease (HD). Coad NA; Jones TJ; Muir KR; Parkes SE; Smith K; Raafat F; Mann JR Pediatr Pathol Lab Med; 1997; 17(6):893-902. PubMed ID: 9353829 [TBL] [Abstract][Full Text] [Related]
11. Flow cytometric measurements of proliferation-associated nuclear antigen p105 and DNA content in non-Hodgkin's lymphomas. Turner RR; Layfield LJ; Bishop PC; Epstein AL; Parker JW Arch Pathol Lab Med; 1989 Aug; 113(8):907-11. PubMed ID: 2569301 [TBL] [Abstract][Full Text] [Related]
12. Comparison of the DNA content in low and high grade non-Hodgkin lymphomas. Ruschenburg L; Misselwitz W; Korabiowska M; Droese M Anticancer Res; 1998; 18(3A):1617-20. PubMed ID: 9673379 [TBL] [Abstract][Full Text] [Related]
13. DNA ploidy and cell kinetic characteristics in canine non-Hodgkin's lymphoma. Teske E; Rutteman GR; Kuipers-Dijkshoorn NJ; van Dierendonck JH; van Heerde P; Cornelisse CJ Exp Hematol; 1993 Apr; 21(4):579-84. PubMed ID: 8462667 [TBL] [Abstract][Full Text] [Related]
15. Fibrosarcoma versus fibromatoses and cellular nodular fasciitis. A comparative study of their proliferative activity using proliferating cell nuclear antigen, DNA flow cytometry, and p53. Oshiro Y; Fukuda T; Tsuneyoshi M Am J Surg Pathol; 1994 Jul; 18(7):712-9. PubMed ID: 7517104 [TBL] [Abstract][Full Text] [Related]
16. Association of DNA content and proliferative activity with clinical outcome in patients with diffuse mixed cell and large cell non-Hodgkin's lymphoma. Wooldridge TN; Grierson HL; Weisenburger DD; Armitage JO; Sanger WG; Collins MM; Pierson JL; Pauza ME; Fordyce R; Purtilo DT Cancer Res; 1988 Nov; 48(22):6608-13. PubMed ID: 3052808 [TBL] [Abstract][Full Text] [Related]
17. Prognostic relevance of ploidy and proliferative activity evaluation by flow cytometry in poor prognosis non-Hodgkin's lymphomas. De Lena M; Barletta A; Marzullo F; Lorusso V; Berardi F; Tommasi S; Mangia A; Paradiso A Haematologica; 1992; 77(1):84-6. PubMed ID: 1398287 [TBL] [Abstract][Full Text] [Related]
18. Comparative cytophotometric analysis of reactive lymphoid hyperplasia and low malignant non-Hodgkin lymphoma. Ruschenburg I; Peters D; Korabiowska M; Droese M Anticancer Res; 1998; 18(3A):1613-6. PubMed ID: 9673378 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of proliferating cells in acute leukemia with antibodies to proliferating cell nuclear antigen and Ki-67 monoclonal antibodies. Inoue T; Yamane T; Park K; Im T; Tatsumi N; Okuda K Arch Pathol Lab Med; 1993 Oct; 117(10):969-72. PubMed ID: 8105766 [TBL] [Abstract][Full Text] [Related]
20. Cell proliferation in renal cell carcinoma. A clinical study with special reference to prognosis. Larsson P Scand J Urol Nephrol Suppl; 1994; 165():1-48. PubMed ID: 7871395 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]